Trial Profile
A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of TOP1288 Oral Single Ascending and Multiple Doses in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs TOP 1288 (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions
- Sponsors TopiVert
- 08 Jan 2018 Results presented in a TopiVert media release.
- 06 Jul 2017 Status changed from recruiting to completed.
- 28 Feb 2017 Status changed to recruiting.